Causes Of Abnormal Heart Rhythms - Articles

Sort by: Newest Most Comments Relevance

FDA Drug Safety Communication: Abnormal heart rhythms associated with use of Anzemet (dolasetron mesylate) by FDA Posted Fri 17 Dec 2010 11:19am Data Summary Safety Announcement [12-17-2010] The U.S. Food and Drug Administration (FDA) is informing patients and healthcare professionals that the injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chemotherapy (CINV ... Read on »

Study links moderate drinking to abnormal heart rhythm by Robyn Nazar, RN BSN Posted Thu 04 Oct 2012 12:00am Guest Post by Health News Watch Heart patients who drink moderately are have been found to have increased risks of suffering from a common heart rhythm problem, says a new study, highlighting that older adults with heart disease or advanced diabetes were more apt to develop atrial fibrillation than peers who drank less. According to ... Read on »

FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide) by FDA Posted Thu 25 Aug 2011 3:51pm Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [8-24-2011] The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa (citalopram hydrobromide; also marketed a ... Read on »

Anzemet (dolasetron mesylate): Drug Safety Communication - Reports of Abnormal Heart Rhythms by FDA Posted Fri 17 Dec 2010 1:08pm [Posted 12/17/2010] AUDIENCE: Oncology, Cardiology ISSUE: FDA notified healthcare professionals that a contraindication is being added to the prescribing information advising that the injection form of Anzemet (dolasetron mesylate) should no longer be used to prevent nausea and vomiting associated with cancer chem ... Read on »

FDA Approves Xarelto to Prevent Stroke in People with Common Type of Abnormal Heart Rhythm by Medline Plus Posted Sat 05 Nov 2011 8:36am FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm The U.S. Food and Drug Administration today approved the anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation). Atrial fibrillation occurs i ... Read on »

FDA Drug Safety Communication: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms by FDA Posted Thu 21 Oct 2010 11:31am Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [10-21-2010] The U.S. Food and Drug Administration is notifying the public that new risk information has been added to the label of the antiviral drug Invira ... Read on »

Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses by FDA Posted Wed 24 Aug 2011 9:46am [Posted 08/24/2011] AUDIENCE: Psychiatry, Cardiology ISSUE: FDA notified healthcare professionals and patients that the antidepressant Celexa (citalopram hydrobromide) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. Changes i ... Read on »

Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms by FDA Posted Thu 15 Sep 2011 3:00pm [Posted 09/15/2011] AUDIENCE: Oncology, Anesthesiology ISSUE: FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran (ondansetron, ondansetron hydrochloride and generics). Ondansetron may increase the risk of developing prolongation of the ... Read on »

Big Guys More at Risk for Abnormal Heart Rhythm by DiseaseProof Medical Doctor

Posted Mon 20 Apr 2009 11:12pm New findings in the European Heart Journal reveal older men who were big in their 20s are more likely to suffer from atrial fibrillation, i.e. abnormal heart rhythm. The study, started in 1970, involved more than 7,000 men, ages 45 to 55, and asked participants to state their weight at 20 years old. Results showed atrial fibrillation increase ... Read on »

Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm by FDA Posted Thu 21 Oct 2010 10:55am [Posted 10/21/2010] AUDIENCE: Cardiology, Infectious Disease ISSUE: FDA notified healthcare professionals of new risk information added to the Warnings and Precautions, Contraindications, and Clinical Pharmacology sections of the antiviral drug Invirase (saquinavir), describing a potential change in the electrical ... Read on »